Esophageal Cancer Immunotherapy

The search strategy employed the following query: TS = ((esophageal cancer OR esophagus cancer OR esophageal carcinoma OR esophagus carcinoma OR carcinoma of the esophagus OR esophageal tumor OR esophagus tumor) AND (Immunotherapy OR Immunotherapies OR immunotherapeutic)). The time range for the search spanned from January 1, 2015, to October 14, 2024, covering all relevant literature on esophageal cancer immunotherapy published in the past decade. This period was chosen to analyze research trends and recent advancements. The inclusion criteria for the literature included the following: article type (research articles and reviews), English language, research topic related to esophageal cancer immunotherapy, and full-text availability. Exclusion criteria included retracted articles, unavailable full-text documents, non-English language articles, and those deemed irrelevant to esophageal cancer immunotherapy after abstract review. All filtered literature was exported in plain text format, including complete records to ensure the completeness and accuracy of subsequent analyses